Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge

February 12, 2018 updated by: Joke Wuyts, KU Leuven

Title of the research:

Exploratory study to inventory opportunities to optimize continuity of pharmacotherapy at hospital discharge

Study area:

Care region Leuven (individual interviews), care region Bruges (individual interviews) and care region Mortsel (One focus group).

Aims:

From an explorative angle, the study aims to identify hurdles, barriers, facilitators and needs that general practitioners and community pharmacists experience with patients who have recently been discharged from a hospital. From a feasibility standpoint, the study aims to investigate what supportive actions are feasible and useful to optimize the care process upon hospital discharge. For this purpose, a discharge document for the community pharmacist will be shown to the healthcare professionals. The HCP will be given the opportunity to give feedback on this document.

Study design:

A non-interventional, qualitative study is set up using face-to-face, semi-structured interviews and a focus group.

Study population:

Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.

Number of health care professionals:

Individual interviews will be organised until there is saturation of information and no new elements are provided in the interviews. At least five community pharmacists and five general practitioners will be interviewed per care region. In addition, a focus group will take place in care region Mortsel.

Procedures:

Upon an informed consent of the healthcare professional, a semi-structured face-to-face interview will take place. The interview will focus on concrete patient cases, provided by the healthcare professional, as well as a fictional case of the researcher. In the focus group, data of the individual interviews will be presented and the relevance and completeness of the information will be assessed. Finally, the aim of the focus group is to reach a consensus on the research questions.

Study Overview

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Belgium, 3000
        • KU Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Community pharmacists and general practitioners that are employed in the study region and that are considered opinion leaders.

Description

Inclusion Criteria:

  • Profession: general practitioner or community pharmacists
  • Employment in care regions Leuven, Bruges or Kontich
  • Experience in daily practice
  • Interest in research or optimisation of the healthcare profession. For example supervisors of an internship, local coordinators of general practitioners or pharmacy clusters and active HCP that are linked with professional associations.

Exclusion Criteria:

None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Pharmacists-Leuven
Individual interviews with approximately 5 pharmacists
Pharmacists-Bruges
Individual interviews with approximately 5 pharmacists
Pharmacists-Mortsel
A focus group with pharmacists and general practitioners
General Practitioners-Leuven
Individual interviews with approximately 5 general practitioners
General Practitioners-Bruges
Individual interviews with approximately 5 general practitioners
General Practitioners-Mortsel
A focus group with pharmacists and general practitioners

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Semi-structured interviews/focus group: Experienced problems and solutions
Time Frame: Approximately 1 hour
Experienced problems during counseling of discharged older patients and potential solutions
Approximately 1 hour
Semi-structured interviews: Strengths and weaknesses of a proposal for a discharge document for community pharmacist (using open ended questions)
Time Frame: Approximately 1 hour
During the interviews, a proposal for a discharge document will be shown to healthcare professionals. They will be asked to give their feedback on the content of the document (not applicable for the focus group)
Approximately 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (ACTUAL)

April 1, 2016

Study Completion (ACTUAL)

April 1, 2016

Study Registration Dates

First Submitted

January 25, 2016

First Submitted That Met QC Criteria

July 19, 2017

First Posted (ACTUAL)

July 21, 2017

Study Record Updates

Last Update Posted (ACTUAL)

February 13, 2018

Last Update Submitted That Met QC Criteria

February 12, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • S58480

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Discharge

3
Subscribe